Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Pharmacological and clinical profile of Cetuximab Injection (Erbitux)].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica - 1 Jun 2009

Kaneko Takehiko, Mizushima Masaya

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Antibody-Dependent Cell Cytotoxicity
Share to Cetuximab
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colonic Neoplasms

Share to Immunoglobulin G

Share to Neovascularization, Pathologic

Share to ras Proteins

Source

Identifiers

PMID: 19521032
DOI: 10.1254/fpj.133.341

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Pharmacological and clinical profile of Cetuximab Injection (Erbitux)].PMID 19521032Read ↗

[Pharmacological and clinical profiles of panitumumab injection (Vectibix®)].Semantic proximity Read ↗

[Individualized drug therapy].Semantic proximity Read ↗

[New pharmacology techniques and methods in oncology].Semantic proximity Read ↗

[From ASCO and WCLC 2005 to the clinical practice: targeted therapies].Semantic proximity Read ↗

Cetuximab, its clinical use and future perspectives.Semantic proximity Read ↗

[EGFR pathway and mechanism of action of tyrosine kinase inhibitors].Semantic proximity Read ↗

[Perspectives and future developments of epidermal growth factor receptors inhibitors].Semantic proximity Read ↗

Fatal infusion reaction to cetuximab: the need for predictive risk factors and safer patient selection.Semantic proximity Read ↗

[Clinical manifestation of targeted drugs in individualized therapy of malignant tumors].Semantic proximity Read ↗

[BRAF inhibitor and MEK inhibitor].Semantic proximity Read ↗

[Gene mutation (KRAS, BRAF, PIK3CA) and clinical benefit of anti-EGFR antibody].Semantic proximity Read ↗

[Treatment choice after EGFR-TKI resistance].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.